How Pierre Fabre Laboratories enhances their antibody developability platform with NanoTemper’s Prometheus Panta
Posted in Resources
| Download the Case Study
In this case study, learn how Dr Elsa Wagner from Pierre Fabre Laboratories put together a comprehensive developability platform for monoclonal antibodies (mAbs), using combined thermal and colloidal stability parameters from the Prometheus Panta instrument.
You’ll learn about:
- How Pierre Fabre Laboratories approaches developability assessment for mAbs candidates
- The criteria that guided her decision for the Prometheus Panta as a solution for her developability platform
- The benefits of combining simultaneous thermal and colloidal stability measurements for confident ranking of mAbs candidates
